AI Is Transforming Drug Discovery: Eli Lilly Signs $2.75 Billion Deal with Insilico Medicine
AI Is Transforming the Way Medicines Are Developed Artificial intelligence is rapidly changing the pharmaceutical industry. Major drugmakers are investing billions in AI tools to speed up the discovery and development of new medicines. A recent standout example is the collaboration between Eli Lilly and Insilico Medicine. Announced on March 29, 2026, the deal is…